Elequin Capital’s Johnson & Johnson JNJ Stock Holding History

Elequin Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-172	Closed	-$42K	–	814
2026 Q1	$42K	Buy	+172	New	+$40.1K	﹤0.01%	183

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Elequin Capital's JNJ Position: Q2 2026 in Review

Elequin Capital sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 172 shares — an estimated $42K sold.

Elequin Capital first reported a position in JNJ in Q1 2026 and held it in 1 quarter. The position peaked at $42K in Q1 2026. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Elequin Capital reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
Elequin Capital sold 172 Johnson & Johnson shares in Q2 2026, an estimated $42K.
Elequin Capital first reported a position in Johnson & Johnson in Q1 2026 and held it in 1 quarter.
Elequin Capital's Johnson & Johnson position peaked at $42K in Q1 2026.
4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.